IDx, a privately held AI diagnostics company built on University of Iowa research, announced today that it has filed its De Novo submission to the Food and Drug Administration (FDA) for IDx-DR, an AI-based system for the autonomous detection of diabetic retinopathy — a leading cause of blindness. The FDA has granted IDx-DR with a “Breakthrough Device” designation, which means the submission will...

The University of Iowa Office of the Vice President for Research and Economic Development is cosponsoring the Eastern Iowa Biotech Spotlight Tour, which showcases the pharmaceutical, chemical, nutraceutical industries that make up Iowa’s Creative Corridor biotech companies. The event, which runs Oct. 4-5, is free and open to the public though registration is required. Click here to register for...